Voxelotor (GBT440), a first ‐in‐class hemoglobin oxygen‐affinity modulator, has promising and reassuring preclinical and clinical data
Source: American Journal of Hematology - Category: Hematology Authors: Jeremie H. Estepp Tags: Commentary Source Type: research
More News: Hematology